Kevin O'Boyle

Kevin C.
O'Boyle is currently an Independent Director at Carlsmed, Inc. since 2024, iRhythm Holdings, Inc. starting 2025, and Outset Medical, Inc. starting 2025.
He serves as Director at San Diego Hall of Champions and ChromaCode, Inc. since 2021.
He is an Advisor at HighCape Partners Management LLC and HighCape Capital Acquisition Corp.
II since 2020.
Former roles include Chairman at GenMark Diagnostics, Inc. from 2020 to 2021; Director at NeoTract, Inc. in 2017; Independent Director at ZELTIQ Aesthetics, Inc. from 2011 to 2017; Independent Non-Executive Director at Tornier NV from 2013 to 2019; Independent Director at Project Sage Oldco, Inc. from 2014 to 2023; Independent Director at Durata Therapeutics, Inc. from 2012 to 2014; Independent Non-Executive Director at Wright Medical Group NV from 2010 to 2020; Independent Director at Nevro Corp.
from 2019 to 2025; Chief Financial Officer & Senior VP-Operations at Clarient, Inc.; Chief Financial Officer at NuVasive LLC from 2003 to 2009; Chief Financial Officer & Senior Vice President at Shire Regenerative Medicine, Inc. from 2010 to 2011; Chief Financial Officer & SVP-Operations at Albert Fisher Group Plc and Albert Fisher North America, Inc.; Vice President & Controller at American Cablesystems Corp.; Advisor at HighCape Capital Acquisition Corp.; and Chief Financial & Operating Officer at Chroma Vision Medical Systems, Inc. from 1996 to 2002.
Education includes undergraduate studies at Rochester Institute of Technology.